Accelerated Hypofractionated Radiation Therapy for the Central and Ultracentral Tumors of the Lung - Analysis of Doses to the Organs at Risk

被引：0
|
作者：
Karasawa, K. [1 ]
Kitou, S. [1 ]
Machitori, Y. [1 ]
Hayakawa, S. [1 ]
Ito, K. [1 ]
Ogawa, H. [1 ]
Shimizuguchi, T. [1 ]
Taguchi, K. [1 ]
Shibata, Y. [1 ]
机构：
[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2256
引用
收藏
页码：E116 / E116
页数：1
相关论文
共 50 条
  • [21] Is Stereotactic Ablative Radiation Therapy Safe for the Treatment of Ultracentral Lung Tumors? A Systematic Review
    Laba, J. M.
    Chen, H.
    Boldt, G.
    Palma, D. A.
    Louie, A. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E471 - E472
  • [22] Evaluation of the organs at risk doses for lung tumors in gated and conventional radiotherapy
    Shahzadeh, Sara
    Gholami, Somayeh
    Mahmood, Seyed
    Aghamiri, Reza
    Mahani, Hojjat
    Nabavi, Mansoure
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (04) : 726 - 730
  • [23] Hypofractionated stereotactic Radiation therapy of lung tumors: Effect of computational algorithm
    Schill, S.
    Stern, C.
    Andratschke, N.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 145 - 145
  • [24] Outcomes and Toxicity in Patients Treated with Stereotactic Body Radiation Therapy for Ultracentral Lung Tumors at a Single Institution
    Buchberger, D. S.
    Busch, C.
    Xia, P.
    Reddy, C. A.
    Stephans, K. L.
    Videtic, G. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E8 - E9
  • [25] Accelerated Hypofractionated Radiotherapy for Central Lung Tumors Unsuitable for Stereotactic Body Radiotherapy Or Concurrent CRT
    Zeng, K. L.
    Poon, I.
    Ung, Y.
    Zhang, L.
    Cheung, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S638 - S638
  • [26] Doses to organs at risk in conformational and stereotactic body radiation therapy: Liver
    Debbi, K.
    Janoray, G.
    Scher, N.
    Deutsch, E.
    Mornex, F.
    CANCER RADIOTHERAPIE, 2017, 21 (6-7): : 604 - 612
  • [27] Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity
    Rock, Crosby
    Sood, Sumit
    Cao, Ying
    Shelton, Shary
    Chen, Ronald C.
    Wang, Fen
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [28] Accelerated hypofractionated radiation therapy with neoadjuvant and concomitant hormone therapy for intermediate risk prostate cancer
    Yassa, M.
    Fortin, B.
    Fortin, M-A.
    Lambert, C.
    Nguyen, T. V.
    Bahary, J-P.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S439 - S439
  • [29] Accelerated hypofractionated radiation therapy with neoadjuvant and concomitant hormone therapy for intermediate risk prostate cancer
    Yassa, M.
    Fortin, B.
    Lambert, C.
    Nguyen, T.
    Fortin, M.
    Bahary, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S347 - S348
  • [30] Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity
    Crosby Rock
    Sumit Sood
    Ying Cao
    Shary Shelton
    Ronald C. Chen
    Fen Wang
    Radiation Oncology, 18
12345